2009
DOI: 10.1016/j.vetmic.2009.03.003
|View full text |Cite
|
Sign up to set email alerts
|

An attenuated live vaccine based on highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) protects piglets against HP-PRRS

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
97
0
8

Year Published

2014
2014
2018
2018

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 128 publications
(108 citation statements)
references
References 13 publications
3
97
0
8
Order By: Relevance
“…The virulent PRRSV strain HuN4 (GenBank accession no. EF635006) and the attenuated vaccine strain HuN4-F112 were maintained and titrated in Marc-145 cells as described previously (Tian et al, 2009;Tong et al, 2007) and were stored at 280 uC.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…The virulent PRRSV strain HuN4 (GenBank accession no. EF635006) and the attenuated vaccine strain HuN4-F112 were maintained and titrated in Marc-145 cells as described previously (Tian et al, 2009;Tong et al, 2007) and were stored at 280 uC.…”
Section: Methodsmentioning
confidence: 99%
“…Seven serum samples were collected from four pigs 21 days after intramuscular inoculation with attenuated PRRSV vaccine strain HuN4-F112 (Tian et al, 2009) and from three specific-pathogen-free (SPF) pig sera. ELISA showed that all four PRRSV HuN4-F112-immunized pigs produced PRRSV-specific antibodies; the three SPF pig sera had no PRRSV-specific antibodies (Table 1).…”
Section: Anti-prrsv Immune Serum Enhances Prrsv Infection In Porcine mentioning
confidence: 99%
See 1 more Smart Citation
“…The PRRSV HuN4 strain (GenBank accession number: EF635006, http://www.ncbi.nlm.nih.gov/nuccore/EF635006) was first isolated in 2006 and characterized by extensive amino acid mutations in GP5 protein and 30 aa deletions in Nsp2 compared with CH1a strain (52). HuN4-F112, a virulence-attenuated vaccine strain of HuN4, was obtained by passaging the HP-PRRSV HuN4 on Marc-145 cells (112th passage) (53). SDA2 (GenBank accession number: JX878379.1, http://www.ncbi.…”
Section: Cells and Virusesmentioning
confidence: 99%
“…Several live attenuated North American-lineage PRRSV vaccines, such as Ingelvac1 ATP, RespPRRS MLV, RespPRRS/ Repro1 ATP, and CH-1R, have been successfully employed in field [7], and induce higher protection rates than with inactivated vaccines. To respond to the recently emerged HP-PRRSV, new live attenuated vaccines were developed by passaging HP-PRRSV isolates in MARC-145 cell lines [7][8][9].…”
Section: Introductionmentioning
confidence: 99%